Joshua D. Stender, Ph.D. - Publications

Affiliations: 
2008 University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
Area:
Biochemistry

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Cohen Katsenelson K, Stender JD, Kawashima AT, Lordén G, Uchiyama S, Nizet V, Glass CK, Newton AC. PHLPP1 counter-regulates STAT1-mediated inflammatory signaling. Elife. 8. PMID 31408005 DOI: 10.7554/Elife.48609  0.4
2019 Fonseca GJ, Tao J, Westin EM, Duttke SH, Spann NJ, Strid T, Shen Z, Stender JD, Sakai M, Link VM, Benner C, Glass CK. Diverse motif ensembles specify non-redundant DNA binding activities of AP-1 family members in macrophages. Nature Communications. 10: 414. PMID 30679424 DOI: 10.1038/S41467-018-08236-0  0.4
2019 Katsenelson KC, Stender JD, Kawashima AT, Lordén G, Uchiyama S, Nizet V, Glass CK, Newton AC. Author response: PHLPP1 counter-regulates STAT1-mediated inflammatory signaling Elife. DOI: 10.7554/Elife.48609.021  0.4
2017 Stender JD, Nwachukwu JC, Kastrati I, Kim Y, Strid T, Yakir M, Srinivasan S, Nowak J, Izard T, Rangarajan ES, Carlson KE, Katzenellenbogen JA, Yao XQ, Grant BJ, Leong HS, et al. Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells. Molecular Cell. 65: 1122-1135.e5. PMID 28306507 DOI: 10.1016/J.Molcel.2017.02.008  0.4
2017 Katsenelson KC, Stender JD, Glass CK, Newton AC. Abstract 4488: Tumor suppressor phosphatase PHLPP1 regulates transcription factor activity and gene expression in inflammation Cancer Research. 77: 4488-4488. DOI: 10.1158/1538-7445.Am2017-4488  0.4
2016 Meitinger F, Anzola JV, Kaulich M, Richardson A, Stender JD, Benner C, Glass CK, Dowdy SF, Desai A, Shiau AK, Oegema K. 53BP1 and USP28 mediate p53 activation and G1 arrest after centrosome loss or extended mitotic duration. The Journal of Cell Biology. 214: 155-66. PMID 27432897 DOI: 10.1083/Jcb.201604081  0.56
2016 Bhatt S, Stender JD, Joshi S, Wu G, Katzenellenbogen BS. OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells. Oncogene. PMID 27065334 DOI: 10.1038/Onc.2016.105  0.56
2015 Frasor J, El-Shennawy L, Stender JD, Kastrati I. NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms. Molecular and Cellular Endocrinology. 418: 235-9. PMID 25450861 DOI: 10.1016/J.Mce.2014.09.013  0.56
2014 Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann NJ, Stender JD, Chun HB, Garner H, Geissmann F, Glass CK. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell. 159: 1327-40. PMID 25480297 DOI: 10.1016/J.Cell.2014.11.023  0.56
2014 Reyes G, Niederst M, Cohen-Katsenelson K, Stender JD, Kunkel MT, Chen M, Brognard J, Sierecki E, Gao T, Nowak DG, Trotman LC, Glass CK, Newton AC. Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output. Proceedings of the National Academy of Sciences of the United States of America. 111: E3957-65. PMID 25201979 DOI: 10.1073/Pnas.1404221111  0.56
2014 Stender JD, Kastrati I, Yakir M, Frasor J, Glass CK. Abstract LB-148: Inflammatory cytokines alter the sensitivity of breast cancer cells to endocrine treatments Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-148  0.4
2013 Kaikkonen MU, Spann NJ, Heinz S, Romanoski CE, Allison KA, Stender JD, Chun HB, Tough DF, Prinjha RK, Benner C, Glass CK. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Molecular Cell. 51: 310-25. PMID 23932714 DOI: 10.1016/J.Molcel.2013.07.010  0.56
2013 Stender JD, Glass CK. Epigenomic control of the innate immune response. Current Opinion in Pharmacology. 13: 582-7. PMID 23816801 DOI: 10.1016/J.Coph.2013.06.002  0.56
2012 Stender JD, Pascual G, Liu W, Kaikkonen MU, Do K, Spann NJ, Boutros M, Perrimon N, Rosenfeld MG, Glass CK. Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20. Molecular Cell. 48: 28-38. PMID 22921934 DOI: 10.1016/J.Molcel.2012.07.020  0.56
2011 Stender JD, Stossi F, Funk CC, Charn TH, Barnett DH, Katzenellenbogen BS. The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 25: 1699-709. PMID 21868451 DOI: 10.1210/Me.2011-0102  0.56
2010 Stender JD, Kim K, Charn TH, Komm B, Chang KC, Kraus WL, Benner C, Glass CK, Katzenellenbogen BS. Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation. Molecular and Cellular Biology. 30: 3943-55. PMID 20547749 DOI: 10.1128/Mcb.00118-10  0.56
2010 Kadandale P, Stender JD, Glass CK, Kiger AA. Conserved role for autophagy in Rho1-mediated cortical remodeling and blood cell recruitment. Proceedings of the National Academy of Sciences of the United States of America. 107: 10502-7. PMID 20498061 DOI: 10.1073/pnas.0914168107  0.4
2010 Stender JD, Glass CK. Nuclear receptor coactivators Handbook of Cell Signaling, 2/E. 3: 1999-2004. DOI: 10.1016/B978-0-12-374145-5.00244-8  0.56
2007 Stender JD, Frasor J, Komm B, Chang KC, Kraus WL, Katzenellenbogen BS. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation. Molecular Endocrinology (Baltimore, Md.). 21: 2112-23. PMID 17550982 DOI: 10.1210/Me.2006-0474  0.56
2004 Acevedo ML, Lee KC, Stender JD, Katzenellenbogen BS, Kraus WL. Selective recognition of distinct classes of coactivators by a ligand-inducible activation domain. Molecular Cell. 13: 725-38. PMID 15023342 DOI: 10.1016/S1097-2765(04)00121-2  0.56
Show low-probability matches.